Valitkaa asuinmaanne alla olevasta listasta tai painakaa tästä palataksenne päävalikkoon.
Ette ole lain nojalla oikeutettu katsomaan tätä asiakirjaa.
Lukekaa alla oleva tiedote huolellisesti ennen kuin päätätte painaa alla olevaa linkkiä.
|
Q3 |
Q3 |
Q1-Q3 |
Q1-Q3 |
| ||
|
|
2009 |
2008 |
2009 |
2008 |
FY 2008 | |
|
|
|
| ||||
|
Turnover |
EUR '000 |
826 |
- |
2,604 |
- |
- |
|
Operating profit (loss) |
EUR '000 |
(15,303) |
(4,955) |
(23,208) |
(9,576) |
(4,296) |
|
Profit (loss) before taxes |
EUR '000 |
(15,314) |
(9,001) |
(30,003) |
(13,452) |
(8,033) |
|
Earnings per share |
EUR |
(0.04) |
(0.03) |
(0.08) |
(0.05) |
0.03 |
|
Capital expenditure |
EUR '000 |
24,315 |
100,128 |
82,052 |
273,030 |
429,086 |
|
Net interest-bearing debt |
EUR '000 |
354,130 |
100,131 |
354,130 |
100,131 |
285,467 |
|
Debt-to-equity ratio |
84.2 % |
28.3 % |
84.2 % |
28.3 % |
67.3 % | |
|
Cash and cash equivalents
at the end of the period |
EUR '000 |
68,624 |
93,028 |
68,624 |
93,028 |
82,713 |
|
Derivative financial instruments |
EUR '000 |
64,975 |
74,393 |
64,975 |
74,393 |
152,545 |
|
Number of employees at the
end of the period |
283 |
229 |
283 |
229 |
239 |
|
|
|
Q3 2009 |
Q1-Q3 2009 |
2008-2009 |
|
Mining |
||||
|
Blasted ore |
million tonnes |
2.0 |
7.3 |
10.3 |
|
Excavated waste |
million tonnes |
1.0 |
2.9 |
4.2 |
|
Materials handling |
||||
|
Stacked ore |
million tonnes |
1.4 |
5.5 |
8.0 |
|
Bioheapleaching |
||||
|
Ore in primary heap
at end of period |
million tonnes |
8.0 |
8.0 |
8.0 |
|
Metals recovery |
||||
|
Nickel sulphide production |
dry metric tonnes |
208 |
668 |
668 |
|
Nickel metal content |
tonnes |
101 |
325 |
325 |
|
Zinc sulphide production |
dry metric tonnes |
190 |
1,444 |
1,444 |
|
Zinc metal content |
tonnes |
114 |
820 |
820 |
|
|
|||||
|
Unaudited three |
Unaudited three |
Unaudited nine |
Unaudited nine |
Audited twelve | |
|
months to |
months to |
months to |
months to |
months to | |
|
(all amounts in EUR '000) |
30 Sep 09 |
30 Sep 08 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 |
|
Turnover |
826 |
- |
2,604 |
- |
- |
|
Other operating income |
11,599 |
3,402 |
37,152 |
12,568 |
29,810 |
|
Changes in inventories of finished goods and work in progress |
15,100 |
3,773 |
47,177 |
3,773 |
24,006 |
|
Materials and services |
(12,763) |
(4,389) |
(40,267) |
(5,910) |
(20,407) |
|
Employee benefit expenses |
(3,566) |
(3,159) |
(11,631) |
(7,286) |
(8,910) |
|
Depreciation, amortization, depletion and impairment charges |
(9,458) |
(265) |
(25,677) |
(462) |
(5,756) |
|
Other operating expenses |
(17,041) |
(4,317) |
(32,566) |
(12,259) |
(23,039) |
|
Operating profit (loss) |
(15,303) |
(4,955) |
(23,208) |
(9,576) |
(4,296) |
|
Finance income |
8,026 |
514 |
15,039 |
2,799 |
9,219 |
|
Finance cost |
(8,037) |
(4,560) |
(21,834) |
(6,675) |
(12,956) |
|
Finance cost (net) |
(11) |
(4,046) |
(6,795) |
(3,876) |
(3,737) |
|
Loss before income tax |
(15,314) |
(9,001) |
(30,003) |
(13,452) |
(8,033) |
|
|
|||||
|
Income tax expense |
4,565 |
(363) |
8,056 |
(1,895) |
13,865 |
|
Profit (loss) for the period |
(10,749) |
(9,364) |
(21,947) |
(15,347) |
5,832 |
|
Attributable to: |
|||||
|
Equity holders of the Company |
(9,310) |
(7,013) |
(18,415) |
(10,975) |
7,042 |
|
Minority interest |
(1,439) |
(2,351) |
(3,532) |
(4,372) |
(1,210) |
|
(10,749) |
(9,364) |
(21,947) |
(15,347) |
5,832 | |
|
Earnings per share for profit (loss) attributable to the equity holders of the Company (expressed in per share) |
|||||
|
Basic and diluted |
(0.04) |
(0.03) |
(0.08) |
0.05) |
0.03 |
|
|
|||||
|
Unaudited three |
Unaudited three |
Unaudited nine |
Unaudited nine |
Audited twelve | |
|
months to |
months to |
months to |
months to |
months to | |
|
(all amounts in EUR '000) |
30 Sep 09 |
30 Sep 08 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 |
|
|
|
|
|
| |
|
Profit (loss) for the period |
(10,749) |
(9,364) |
(21,947) |
(15,347) |
5,832 |
|
|
|
|
|
| |
|
Other comprehensive income, |
|||||
|
items net of tax |
|
|
|
|
|
|
Available-for-sale financial assets |
- |
- |
- |
(451) |
(451) |
|
Cash flow hedges |
(16,461) |
32,331 |
(63,828) |
42,637 |
90,414 |
|
Other comprehensive income, net of tax |
(16,461) |
32,331 |
(63,828) |
42,186 |
89,963 |
|
|
|||||
|
Total comprehensive income |
(27,210) |
22,967 |
(85,775) |
26,839 |
95,795 |
|
Attributable to: |
|||||
|
Equity holders of the Company |
(22,479) |
18,853 |
(69,478) |
22,685 |
78,922 |
|
Minority interest |
(4,731) |
4,114 |
(16,297) |
4,154 |
16,873 |
|
|
(27,210) |
22,967 |
(85,775) |
26,839 |
95,795 |
|
|
|
||
|
Unaudited |
Audited |
Unaudited | |
|
(all amounts in EUR '000) |
30 Sep 09 |
31 Dec 08 |
30 Sep 08 |
|
|
|||
|
ASSETS |
|||
|
Non-current assets |
|||
|
Property, plant and equipment |
615,195 |
552,459 |
401,794 |
|
Biological assets |
6,368 |
8,152 |
8,249 |
|
Intangible assets |
7,609 |
7,774 |
7,164 |
|
Deferred tax assets |
7,412 |
- |
|
|
Derivative financial instruments |
39,391 |
116,004 |
61,355 |
|
Other receivables |
11,227 |
9,635 |
10,119 |
|
687,202 |
694,024 |
488,681 | |
|
Current assets |
|||
|
Inventories |
82,080 |
31,691 |
4,803 |
|
Trade receivables |
981 |
- |
- |
|
Other receivables |
10,609 |
24,721 |
19,500 |
|
Derivative financial instruments |
30,413 |
40,805 |
13,700 |
|
Cash and cash equivalent |
68,624 |
82,713 |
93,028 |
|
192,707 |
179,930 |
131,031 | |
|
Total assets |
879,909 |
873,954 |
619,712 |
|
EQUITY AND LIABILITIES |
|||
|
|
|||
|
Equity attributable to equity holders of the parent |
|||
|
Share capital |
80 |
80 |
80 |
|
Share premium |
8,086 |
8,086 |
8,086 |
|
Other reserves |
416,554 |
334,019 |
333,533 |
|
Hedge reserve |
21,269 |
72,332 |
34,111 |
|
Retained earnings |
(44,516) |
(26,101) |
(44,119) |
|
401,473 |
388,416 |
331,691 | |
|
Minority interest in equity |
19,119 |
35,470 |
22,745 |
|
Total equity |
420,592 |
423,886 |
354,436 |
|
|
|||
|
Non-current liabilities |
|||
|
Borrowings |
412,852 |
367,955 |
193,135 |
|
Derivative financial instruments |
3,487 |
1,985 |
662 |
|
Deferred tax liabilities |
- |
23,070 |
22,044 |
|
Provisions |
1,018 |
944 |
423 |
|
417,357 |
393,954 |
216,264 | |
|
Current liabilities |
|||
|
Borrowings |
9,912 |
224 |
25 |
|
Trade payables |
19,401 |
45,283 |
41,819 |
|
Other payables |
11,305 |
8,294 |
7,134 |
|
Derivative financial instruments |
1,342 |
2,279 |
- |
|
Provisions |
- |
34 |
34 |
|
41,960 |
56,114 |
49,012 | |
|
Total liabilities |
459,317 |
450,068 |
265,276 |
|
Total equity and liabilities |
879,909 |
873,954 |
619,712 |
|
|
||||||
|
Unaudited
three |
Unaudited three |
Unaudited nine |
Unaudited nine |
Audited twelve | ||
|
months to |
months to |
months to |
months to |
months to | ||
|
(all amounts in EUR '000) |
30 Sep 09 |
30 Sep 08 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 | |
|
Cash flows from operating activities |
||||||
|
|
||||||
|
Profit (loss) for the period |
(10,749) |
(9,364) |
(21,947) |
(15,347) |
5,832 | |
|
Adjustments for |
||||||
|
Tax |
(4,565) |
363 |
(8,056) |
1,895 |
(13,865) | |
|
Depreciation and amortization |
9,458 |
265 |
25,677 |
462 |
5,756 | |
|
Other non-cash income and expenses |
603 |
922 |
3,327 |
2,430 |
4,780 | |
|
Interest income |
(8,026) |
(514) |
(15,039) |
(2,799) |
(9,219) | |
|
Fair value gains on financial assets at fair value through profit or loss |
10,996 |
(3,003) |
2,806 |
(7,604) |
(24,796) | |
|
Interest expense |
8,037 |
4,560 |
21,834 |
6,675 |
12,956 | |
|
5,754 |
(6,771) |
8,602 |
(14,288) |
(18,556) | ||
|
Change in working capital |
||||||
|
Decrease(+)/increase(-) in other receivables |
2,533 |
9,239 |
9,314 |
12,537 |
4,552 | |
|
Decrease (+)/increase (-) in inventories |
(16,404) |
(4,803) |
(51,122) |
(4,803) |
(30,661) | |
|
Decrease(-)/increase(+) in trade and other payables |
1,783 |
2,154 |
(24,072) |
18,670 |
23,773 | |
|
Change in working capital |
(12,088) |
6,590 |
(65,880) |
26,404 |
(2,336) | |
|
(6,334) |
(181) |
(57,278) |
12,116 |
(20,892) | ||
|
Interest and other finance cost paid |
(4,578) |
(1,169) |
(16,132) |
(4,855) |
(7,468) | |
|
Interest income |
52 |
501 |
3,430 |
956 |
9,581 | |
|
Net cash used in operating activities |
(10,860) |
(849) |
(69,980) |
8,217 |
(18,779) | |
|
Cash flows from investing activities |
||||||
|
|
||||||
|
Acquisition of subsidiary, net of cash acquired |
(54) |
- |
(54) |
- |
- | |
|
Purchases of property, plant and equipment |
(24,182) |
(100,045) |
(81,842) |
(271,802) |
(427,187) | |
|
Purchases of biological assets |
- |
- |
(35) |
(26) |
(26) | |
|
Purchases of intangible assets |
(133) |
(83) |
(175) |
(1,202) |
(1,873) | |
|
Proceeds from sale of property, plant and equipment |
- |
- |
9 |
- |
- | |
|
Proceeds from sale of intangible assets |
- |
- |
49 |
- |
- | |
|
Proceeds from sale of biological assets |
104 |
124 |
104 |
251 |
707 | |
|
Proceeds from government grant related to tangible assets |
- |
- |
5,000 |
- |
- | |
|
Proceeds from government grant related to intangible assets |
- |
204 |
13 |
204 |
203 | |
|
Proceeds from sale of available for sale financial assets |
- |
- |
- |
26,356 |
26,356 | |
|
Purchases of derivative financial instruments |
- |
- |
(1,371) |
(1,371) | ||
|
Proceeds from sale of derivative financial instruments |
- |
- |
- |
- |
- | |
|
Proceeds from sale of financial assets at fair value through |
||||||
|
profit or loss |
- |
- |
- |
1,440 |
1,440 | |
|
Net cash used in investing activities |
(24,265) |
(99,800) |
(76,931) |
(246,150) |
(401,751) | |
|
Cash flows from financing activities |
||||||
|
Proceeds from share issue net of transaction costs |
80,644 |
- |
80,644 |
- |
- | |
|
Proceeds from interest-bearing liabilities |
- |
119,560 |
53,357 |
204,460 |
396,734 | |
|
Payment of interest-bearing liabilities |
(1,154) |
- |
(1,179) |
- |
(20,000) | |
|
Capital investment by minority shareholders |
- |
- |
- |
- |
8 | |
|
Net cash generated in financing activities |
79,490 |
119,560 |
132,822 |
204,460 |
376,742 | |
|
|
||||||
|
Net (decrease)/increase in cash and bank overdrafts |
44,365 |
18,911 |
(14,089) |
(33,473) |
(43,788) | |
|
|
||||||
|
Cash and bank overdrafts at beginning of the period |
24,259 |
74,117 |
82,713 |
126,501 |
126,501 | |
|
Cash and bank overdrafts at end of the period |
68,624 |
93,028 |
68,624 |
93,028 |
82,713 | |
|
A |
B |
C |
D |
E |
F |
G |
H |
I | |||
|
Balance at 1 January 2008
|
16
|
8,086
|
320,671
|
1,106
|
-
|
(33,423)
|
296,456
|
18,591
|
315,047
| ||
|
Total comprehensive
income for 1-9/2008 |
- |
- |
- |
(451) |
34,111 |
(10,975) |
22,685 |
4,154 |
26,839 | ||
|
Transfers within equity,
change of the corporate form |
64 |
- |
(64) |
- |
- |
- |
- |
- |
- | ||
|
Employee share option
scheme |
|||||||||||
|
- value of employee
services |
- |
- |
- |
1,377 |
- |
- |
1,377 |
- |
1,377 | ||
|
Convertible bond,
equity component |
- |
- |
- |
10,894 |
- |
- |
10,894 |
- |
10,894 | ||
|
Restatement to capital
expenditure, which
relates to
previous year |
- |
- |
- |
- |
- |
278 |
278 |
- |
278 | ||
|
Minority interest arising
from subsidiary |
- |
- |
- |
- |
- |
1 |
1 |
- |
1 | ||
|
Balance at 30
September 2008 |
80 |
8,086 |
320,607 |
12,926 |
34,111 |
(44,119) |
331,691 |
22,745 |
354,436 | ||
|
|
|
|
|
|
|
|
|
|
| ||
|
Balance at 31
December 2008 |
80 |
8,086 |
320,607 |
13,412 |
72,332 |
(26,101) |
388,416 |
35,470 |
423,886 | ||
|
|
|
|
|
|
|
|
|
|
| ||
|
Balance at 1
January 2009 |
80 |
8,086 |
320,607 |
13,412 |
72,332 |
(26,101) |
388,416 |
35,470 |
423,886 | ||
|
Total comprehensive
income for
1-9/2009 |
- |
- |
- |
- |
(51 063) |
(18 415) |
(69 478) |
(16 297) |
(85 775) | ||
|
Share issue,
net of transaction
costs |
- |
- |
82,691 |
- |
- |
- |
82,691 |
- |
82,691 | ||
|
External costs
directly
attributable to |
|||||||||||
|
The issue of
new shares |
- |
- |
(2,047) |
- |
- |
- |
(2,047) |
- |
(2,047) | ||
|
Acquisition of
subsidiary, Hyena
Holding AB |
- |
- |
- |
- |
- |
- |
- |
(54) |
(54) | ||
|
Employee share
option scheme |
|||||||||||
|
- value of employee
services |
- |
- |
- |
1,891 |
- |
- |
1,891 |
- |
1,891 | ||
|
Balance at 30
September 2009 |
80 |
8,086 |
401,251 |
15,303 |
21,269 |
(44,516) |
401,473 |
19,119 |
420,592 | ||
|
Inventories |
||
|
|
||
|
(all amounts in EUR '000) |
Unaudited |
Audited |
|
|
30 September |
31 December |
|
|
2009 |
2008 |
|
Raw materials and consumables |
8 819 |
6 655 |
|
Ore on leach pads |
43 911 |
22 965 |
|
Work in progress |
26 225 |
1 041 |
|
Finished products |
1 047 |
- |
|
Advance payments |
2 078 |
1 030 |
|
Inventories total |
82 080 |
31 691 |
|
Derivative financial instruments |
||||||
|
|
||||||
|
Fair values of the derivative financial instruments |
||||||
|
|
||||||
|
(all amounts in EUR '000) |
Unaudited |
Audited |
||||
|
30 September |
31 December |
|||||
|
|
2009 |
2008 |
||||
|
Assets |
Liabilities |
Assets |
Liabilities |
|||
|
|
|
|
|
|||
|
Nickel forwards - cash flow hedges |
46,418 |
- |
135,355 |
- |
||
|
Nickel forwards - held for trading |
7,621 |
- |
3,301 |
- |
||
|
Zinc forwards - held for trading |
122 |
940 |
18,153 |
- |
||
|
Interest rate swaps - held for trading |
- |
3,100 |
- |
2,279 |
||
|
Currency forwards - held for trading |
15,643 |
- |
- |
- |
||
|
Currency options - held for trading |
- |
789 |
- |
1,985 |
||
|
Total |
69,804 |
4,829 |
156,809 |
4,264 |
||
|
Unaudited |
Audited | |||||
|
30 September |
31 December | |||||
|
2009 |
2008 | |||||
|
Assets |
Liabilities |
Assets |
Liabilities | |||
|
Derivative financial instruments |
69,804 |
4,829 |
156,809 |
4,264 | ||
|
Total |
69,804 |
4,829 |
156,809 |
4,264 | ||
|
Less non-current portion |
|
|
|
| ||
|
Nickel forwards - cash flow hedges |
29,860 |
- |
101,797 |
- | ||
|
Nickel forwards - held for trading |
- |
- |
- |
- | ||
|
Zinc forwards - held for trading |
9 |
387 |
14,207 |
- | ||
|
Interest rate swaps - held for trading |
- |
3,100 |
- |
1,985 | ||
|
Currency forwards - held for trading |
9,522 |
- |
- |
- | ||
|
Current portion |
30,413 |
1,342 |
40,805 |
2,279 | ||
|
Quantities of the derivative financial instruments
|
||||||
|
|
Unaudited |
Audited |
||||
|
30 Sep 2009 |
Total |
31 Dec 2008 |
Total | |||
|
Current |
Non-current |
|
Current |
Non-current |
| |
|
|
||||||
|
Nickel forwards - cash flow
hedges, in tonnes |
2,971 |
8,813 |
11,784 |
3,429 |
12,128 |
15,557 |
|
Nickel forwards - held for
trading, in tonnes |
1,763 |
- |
1,763 |
404 |
- |
404 |
|
Zinc forwards - held for
trading, in tonnes |
13,652 |
19,927, |
33,579 |
7,458 |
30,559 |
38,017 |
|
Interest rate swaps - held for
trading, in EUR'000 |
- |
36,636 |
36,636 |
- |
36,636 |
36,636 |
|
Currency forwards - held for
trading, in USD '000 |
127,625 |
32,062 |
159,687 |
- |
- |
- |
|
Currency options - held for
trading, in USD'000 |
64,000 |
- |
64,000 |
209,800 |
- |
209,800 |
|
Borrowings |
||||||
|
|
|
|
||||
|
(all amounts in EUR '000) |
Carrying amount |
Fair value |
||||
|
|
Unaudited |
Audited |
Unaudited |
Audited |
||
|
|
30 Sep |
31 Dec |
30 Sep |
31 Dec |
||
|
Non-current |
2009 |
2008 |
2009 |
2008 |
||
|
Capital loans |
1,405 |
1,405 |
1,405 |
1,405 |
||
|
Project Term Loan Facility |
209,656 |
229,935 |
209,656 |
229,935 |
||
|
Senior Unsecured Convertible
Bonds |
74,813 |
72,842 |
74,813 |
72,842 |
||
|
Railway Term Loan Facility |
30,347 |
25,461 |
30,347 |
25,461 |
||
|
Working capital loan |
44,403 |
- |
44,403 |
- |
||
|
Finance lease liabilities |
13,734 |
1,694 |
13,734 |
1,694 |
||
|
Interest Subsidy Loans |
4,186 |
4,182 |
4,186 |
4,182 |
||
|
Other |
34,308 |
32,436 |
34,308 |
32,436 |
||
|
|
412,852 |
367,955 |
412,852 |
367,955 |
||
|
Current |
||||||
|
Finance lease liabilities |
1,034 |
199 |
1,034 |
199 |
||
|
Project Term Loan Facility |
8,878 |
- |
8,878 |
- |
||
|
Other |
- |
25 |
- |
25 |
||
|
|
9,912 |
224 |
9,912 |
224 |
||
|
Total borrowings |
422,764 |
368,179 |
422,764 |
368,179 |
||
|
Employee-related key figures |
Three
months to |
Three
months to |
Nine
months to |
Nine
months to |
Twelve
months to | |
|
|
30 Sep
2009 |
30 Sep
2008 |
30 Sep
2009 |
30 Sep
2008 |
31 Dec
2008 | |
|
Wages and salaries |
EUR '000 |
3,062 |
2,722 |
9,912 |
6,247 |
5,756 |
|
Average number of
employees |
277 |
210 |
266 |
158 |
178 | |
|
Number of employees
at the end of the
period |
283 |
229 |
283 |
229 |
239 | |
|
Three
months to |
Three
months to |
Nine
months to |
Nine
months to |
Twelve
months to | |
|
Other figures |
30 Sep
2009 |
30 Sep
2008 |
30 Sep
2009 |
30 Sep
2008 |
31 Dec
2008 |
|
Share options
outstanding at the end
of the period |
4,334,500 |
2,285,000 |
4,334,500 |
2,285,000 |
4,442,500 |
|
Number of shares to
be issued against |
|||||
|
the outstanding share
options |
4,334,500 |
2,285,000 |
4,334,500 |
2,285,000 |
4,442,500 |
|
Rights to vote of
shares to be issued
against |
|||||
|
the outstanding share
options |
1.7% |
1.0% |
1.7% |
1.0% |
2.0% |
|
Three
months
to |
Three
months
to |
Nine
months
to |
Nine
months
to |
Twelve
months
to | |||
|
30 Sep 09 |
30 Sep 08 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 | |||
|
Operating
profit
(loss) |
EUR
'000 |
(15,303) |
(4,955) |
(23,208) |
(9,576) |
(4,296) | |
|
Return on
equity |
(2.7%) |
(2.7%) |
(5.2%) |
(4.6%) |
1.6% | ||
|
Equity-to
assets ratio |
48% |
57.2% |
48% |
57.2% |
48.5% | ||
|
Net interest
bearing debt |
EUR
'000 |
354,130 |
100,131 |
354,130 |
100,131 |
285,467 | |
|
Debt-to
equity
ratio |
84.2% |
28.3% |
84.2% |
28.3% |
67.3% | ||
|
Capital
expenditure |
EUR
'000 |
24,315 |
100,128 |
82,052 |
273,030 |
429,086 | |
|
Research &
development
expenditure |
EUR
'000 |
- |
- |
- |
- |
181 | |
|
Property,
plant and
equipment |
EUR
'000 |
615,194 |
401,794 |
615,194 |
401,794 |
552,458 | |
|
Derivative
financial
instruments |
EUR
'000 |
64,975 |
74,393 |
64,975 |
74,393 |
152,545 | |
|
Borrowings |
EUR
'000 |
422,764 |
193,160 |
422,764 |
193,160 |
368,179 | |
|
Cash and
cash
equivalents
at the end
of the period |
EUR
'000 |
68,624 |
93,028 |
68,624 |
93,028 |
82,713 | |
|
Three
months
to |
Three
months
to |
Nine
months
to |
Nine
months
to |
Twelve
months
to | |||
|
Share-
related
key figures |
30 Sep 09 |
30 Sep 09 |
30 Sep 09 |
30 Sep 08 |
31 Dec 08 | ||
|
Earnings per
share |
EUR |
(0.04) |
(0.03) |
(0.08) |
(0.05) |
0.03 | |
|
Equity per
share |
EUR |
1.75 |
1.49 |
1.75 |
1.49 |
1.74 | |
|
Development
of share
price at
London
Stock
Exchange |
|||||||
|
Average
trading
price1 |
EUR |
4.27 |
3.60 |
3.39 |
4.27 |
3.64 |
|
|
GBP |
3.72 |
2.86 |
3.00 |
3.34 |
2.90 |
||
|
Lowest
trading
price1 |
EUR |
3.70 |
2.96 |
1.45 |
3.01 |
1.22 |
|
|
GBP |
3.23 |
2.35 |
1.29 |
2.35 |
0.98 |
||
|
Highest
trading
price1 |
EUR |
4.78 |
4.45 |
4.71 |
5.74 |
5.64 |
|
|
GBP |
4.17 |
3.54 |
4.17 |
4.49 |
4.49 |
||
|
Trading
price at
the end of
the period2 |
EUR |
4.18 |
2.97 |
4.18 |
2.97 |
1.25 |
|
|
GBP |
3.80 |
2.35 |
3.80 |
2.35 |
1.19 |
||
|
Change
during the
period |
11.7% |
(36.4%) |
219.1% |
(21.7%) |
(60.3%) |
||
|
Market
capitalization
at the end
of the
period3 |
EUR
'000 |
1,023,794 |
662,796 |
1,023,794 |
662,796 |
278,475 |
|
|
GBP
'000 |
930,936 |
523,807 |
930,936 |
523,807 |
265,247 |
||
|
Development
in trading
volume |
|||||||
|
Trading
volume |
1000
shares |
35,736 |
24,694 |
119,239 |
63,463 |
84,780 |
|
|
In relation to
weighted
average
number of
shares |
15.5% |
11.1% |
51.9% |
28.5% |
38.0% |
||
|
Development
of share
price at OMX
Helsinki |
|||||||
|
Average
trading price |
EUR |
4.38 |
4.19 |
||||
|
Lowest
trading price |
EUR |
3.75 |
3.05 |
||||
|
Highest
trading price |
EUR |
4.86 |
4.86 |
||||
|
Trading price
at the
end of the
period |
EUR |
4.18 |
4.18 |
||||
|
Change
during
the period |
3.2% |
33.5% |
|||||
|
Market
capitalization
at the end of
the period |
EUR
'000 |
931,708 |
931,708 |
||||
|
Development
in trading
volume |
|||||||
|
Trading
volume |
1000
shares |
45,054 |
86.452 |
||||
|
In relation to
weighted
average
number of
shares |
19.6% |
37.6% |
|||||
|
Adjusted
average
number of
shares |
222 896 718 |
222 896 718 |
222 896 718 |
222 896 718 |
222 896 718 | ||
|
Number of
shares at
the end of
the period |
222 896 718 |
222 896 718 |
222 896 718 |
222 896 718 |
222 896 718 | ||
|
|
|
|
Return on equity |
Profit (loss) for the period/ |
|
(Total equity at the beginning of period +
Total equity at the end of period)/2 | |
|
Equity-to-assets ratio |
Total equity/ |
|
Total assets | |
|
Net interest-bearing debt |
Interest-bearing debt - Cash and cash equivalent |
|
Debt-to-equity ratio |
Net interest-bearing debt/ |
|
Total equity | |
|
Share-related key figures |
|
|
Earnings per share |
Profit (loss) attributable to equity holders of the Company/ |
|
Adjusted average number of shares | |
|
Equity per share |
Equity attributable to equity holders of the Company/ |
|
Adjusted average number of shares | |
|
Market capitalization at the
end of the period |
Number of shares at the end of the period * trading price
at the end of the period |